Literature DB >> 6999898

Dose: a critical factor in cancer chemotherapy.

E Frei, G P Canellos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6999898     DOI: 10.1016/0002-9343(80)90472-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  106 in total

Review 1.  Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?

Authors:  D J Dodwell; E S de Campos; J A Radford
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

2.  Selecting dose-intense drug combinations: metastatic breast cancer.

Authors:  E L Korn; R Simon
Journal:  Breast Cancer Res Treat       Date:  1992-03       Impact factor: 4.872

Review 3.  Adverse effects of cancer chemotherapy. An overview of techniques for avoidance/minimisation.

Authors:  M Nicolson; R C Leonard
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

4.  High-dose chemotherapy with autologous stem cell transplant for breast cancer: what have we learned 25 years later?

Authors:  Yago Nieto; Elizabeth J Shpall
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-04       Impact factor: 5.742

5.  Dose-Dense Chemotherapy: Principles, Clinical Results and Future Perspectives.

Authors:  Marc L Citron
Journal:  Breast Care (Basel)       Date:  2008-08-20       Impact factor: 2.860

Review 6.  Clinical pharmacokinetics-pharmacodynamics of anticancer drugs.

Authors:  W E Evans; M V Relling
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

7.  Tackling the problems of tumour chemotherapy by optimal drug scheduling.

Authors:  Ambili Remesh
Journal:  J Clin Diagn Res       Date:  2013-05-31

Review 8.  Impact of obesity on chemotherapy management and outcomes in women with gynecologic malignancies.

Authors:  Neil S Horowitz; Alexi A Wright
Journal:  Gynecol Oncol       Date:  2015-04-12       Impact factor: 5.482

9.  Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult acute lymphoblastic leukemia (ALL).

Authors:  R Scherrer; K Geissler; P A Kyrle; H Gisslinger; U Jäger; P Bettelheim; K Laczika; G Locker; C Scholten; C Sillaber
Journal:  Ann Hematol       Date:  1993-06       Impact factor: 3.673

10.  Extracorporeal hemofiltration: a model for decreasing systemic drug exposure with intra-arterial chemotherapy.

Authors:  R A Graham; Z H Siddik; D C Hohn
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.